Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 15

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 15
---
 |     |                   |     |                                      |     |                                 |     |                                  |     |                 |     |                                                |
| Mark B. McClellan      |     |                 |     |         |     |                   |     |                                      |     |                                 |     |                                  |     |                 |     |                                                |
| Philip O. Ozuah        |     |                 |     |         |     |                   |     |                                      |     |                                 |     |                                  |     |                 |     |                                                |
| Kimberly A. Ross       |     |                 |     |         |     |                   |     |                                      |     |                                 |     |                                  |     |                 |     |                                                |
| Eric C. Wiseman        |     |                 |     |         |     |                   |     |                                      |     |                                 |     |                                  |     |                 |     |                                                |
| Donna F. Zarcone       |     |                 |     |         |     |                   |     |                                      |     |                                 |     |                                  |     |                 |     |                                                |

#### Nomination Process
The Corporate Governance Committee assesses the Board’s composition as part of the annual self-evaluation of the Board (described in the “Corporate Governance Policies and Practices – Board Evaluations and Board Effectiveness” section of this Proxy Statement). On an ongoing basis, the Corporate Governance Committee engages in Board succession planning, taking into account input from Board discussions and from the Board and committee evaluation process.

Renomination of Current Directors

When considering whether to nominate current directors for re-election, the Corporate Governance Committee and the Board review individual directors’ performance against the expectations for Board membership, as well as how the directors’ skills and experiences support the Company’s mission, values, and strategy and the Board’s needs. The Committee also considers individual directors’ outside commitments to ensure that each director is able to devote the time required to serve as a productive member of the Board.

| The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |     | 13 |

| CORPORATE GOVERNANCE MATTERS |

Identification of New Directors

| Assessment of Needs                                                                                                                                                                                                                                                                                   |     | Identification of Potential Candidates                                                                                                                                                                                         |     | Candidate Review Process                                                                                                                                                                                                                                                                                                                |     | Recommendation                                                                                                                      |
| •The Corporate Governance Committee considers the diversity of skills represented on the Board and focuses on identifying candidates who possess skills and qualifications that are complementary to the existing Board members’ skills and will